Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Total Revenue Chart for Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited (SUNPHARMA) revenue for FY2026 was INR 584.6B, a 11.2% change from FY2025. Sun Pharmaceutical Industries Limited's revenue grew from INR 9.8B in 2004 to INR 584.6B in 2026 (5837.4% over 22 years). Earnings per share grew from INR 15.17 in 2014 to INR 45.60 in 2025 (200.6%). Revenue compound annual growth rate: 5-year CAGR of 11.8%, 10-year CAGR of 7.6%, 20-year CAGR of 19.6%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.